Egg pick up one month ago 15 eggs were retrieved. Now on OCPs complain

Egg pick up one month ago 15 eggs were retrieved. Now on OCPs complaining of excessive heat golf body how to manage

Reading File

Finding Sources

Searching the Web

hot flushes after egg retrieval IVF on OCP management vasomotor symptoms

Reading File

Finding Sources

I now have enough information to provide a comprehensive, clinically relevant answer.

Hot Flushes Post-Egg Pick-Up on OCPs — Clinical Analysis & Management

Understanding the Scenario

This patient had oocyte retrieval 1 month ago (15 eggs retrieved — a robust response, likely a "freeze-all" cycle) and is now on OCPs as a bridging/suppression regimen between cycles. She is experiencing hot flushes (vasomotor symptoms).

Why Is She Getting Hot Flushes on OCPs?

The key principle from Berek & Novak's Gynecology is:

"Vasomotor symptoms are a consequence of estrogen withdrawal, not simply estrogen deficiency. A young woman... will not experience hot flashes until she is treated with estrogens and that therapy is withdrawn."

Several mechanisms are likely at play here:

1. Residual GnRH Agonist Effect (Most Common Cause)

If she received a GnRH agonist (e.g., Lupron/leuprolide) as part of the long protocol or as a trigger/luteal support, its profound pituitary/ovarian suppression can persist for 4–6 weeks after the last dose. This causes a hypo-estrogenic state similar to medical menopause, producing hot flushes — even while on OCPs if the OCP estrogen dose is insufficient to overcome this suppression.

2. OCP with Low Estrogen Dose

Modern OCPs (especially low-dose, 20 µg EE) may not provide enough estrogen to fully counteract the hypo-estrogenic state created by:

Post-stimulation ovarian quiescence (the ovaries are "resting" after heavy stimulation)
Residual GnRH agonist suppression

3. Post-stimulation Hormonal Crash

After controlled ovarian hyperstimulation (COH), the ovaries were massively stimulated. After retrieval, this hormonal "peak" rapidly falls. The subsequent drop in estradiol — even to OCP baseline levels — can feel like withdrawal and trigger vasomotor instability.

4. OCP Brand/Formulation Issue

Some progestin-dominant OCPs (e.g., those with levonorgestrel or desogestrel) have anti-estrogenic properties that may not suppress central thermoregulatory instability adequately.

Management

Step 1: Reassurance — This Is Expected and Transient

Hot flushes in this context are a normal, self-limiting side effect of the post-retrieval hormonal milieu. They typically resolve within 4–8 weeks as the hypothalamic-pituitary-ovarian axis normalizes.

Step 2: Optimize the OCP Regimen

Action	Rationale
Switch to a higher estrogen OCP (30–35 µg EE) if currently on 20 µg	More estrogen to counteract hypo-estrogenic state
Ensure continuous (no pill-free week) OCP use	Pill-free intervals cause estrogen withdrawal → worsens flushes
Consider OCPs with less androgenic/more estrogenic progestins (e.g., drospirenone, dienogest)	Anti-androgenic progestins tend to have a more estrogenic CNS profile

Step 3: Non-Pharmacological Lifestyle Measures

(From Berek & Novak's Gynecology, p. 936–937)

Keep room temperature cool; wear light, layered clothing
Avoid triggers: caffeine, spicy food, alcohol, hot drinks
Maintain healthy weight (overweight women have more severe symptoms)
Stop smoking if applicable
Regular moderate exercise

Step 4: Short-term Add-Back Estrogen (if OCP optimization fails)

In refractory cases during the waiting period between IVF cycles, a low-dose supplemental estradiol (e.g., estradiol patch 25–50 µg/day or oral estradiol 1 mg/day) can be added to the OCP to raise circulating estrogen above the symptom threshold. This is sometimes used in GnRH agonist down-regulation protocols anyway.

Step 5: Rule Out Other Causes

Thyroid dysfunction — TSH (thyroid disease increases post-stimulation stress; Berek & Novak's notes thyroid function should be tested if vasomotor symptoms are atypical or resistant to therapy)
Premature ovarian insufficiency — check FSH/estradiol if symptoms persist after stopping IVF medications
Anxiety/stress — psychological stress amplifies thermoregulatory instability

Step 6: Non-Hormonal Pharmacological Options (if needed)

These are typically reserved for persistent cases and would be unusual in this setting, but include:

Venlafaxine 37.5–75 mg/day (SNRI — most evidence for vasomotor symptoms)
Gabapentin 300 mg TID
Clonidine 0.1 mg BD
Neurokinin 3 receptor antagonists (fezolinetant — newer option with phase 3 data) — Katzung's Pharmacology, 16th ed.

Summary Algorithm

Post-egg retrieval hot flushes on OCPs
              ↓
Likely: residual GnRH suppression + post-stimulation estrogen drop
              ↓
1. Reassure — transient, expected
2. Optimize OCP → switch to 30–35 µg EE, continuous use
3. Lifestyle: cool environment, avoid triggers
4. If persists >2–4 weeks → add estradiol supplementation
5. Rule out thyroid dysfunction (TSH)
6. If severe → consider SNRI (venlafaxine) short-term
              ↓
Resolution expected within 4–8 weeks as axis recovers

Key clinical point: The most important immediate action is to continue the OCP without pill-free intervals (continuous use eliminates withdrawal-driven flushes) and consider upgrading to a 30–35 µg EE formulation. Reassurance that this is a predictable, self-limiting consequence of ovarian hyperstimulation is essential for patient confidence.

This is a shared conversation. Sign in to Orris to start your own chat.